Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence.
R Malcolm, J W Moore, D K Kajdasz...
https://pubmed.ncbi.nlm.nih.gov/9134073Completed
Phase 3
Age: 21Years - 50Years
All Genders
ID00000248
Dose Response Trial of Pergolide for Cocaine Dependence
Led by Medical University of South Carolina · Updated on 2018-05-16
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Medical University of South Carolina
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
CONDITIONS
Official Title
Dose Response Trial of Pergolide for Cocaine Dependence - 1
Who Can Participate
Age: 21Years - 50Years
All Genders
Eligibility Criteria
You may qualify if you...
Please contact site for information.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 1 location
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here